
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Merck KGaA
Market Cap: €47.5b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€109.35
7D
-1.5%
1Y
-18.4%
SCHOTT Pharma KGaA
Market Cap: €2.0b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€13.36
7D
-2.8%
1Y
-46.3%
Bayer
Market Cap: €38.8b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€39.53
7D
-1.2%
1Y
62.1%
Evotec
Market Cap: €772.2m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.36
7D
0.07%
1Y
-33.6%
Formycon
Market Cap: €350.1m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.82
7D
0.5%
1Y
-25.3%